SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-18-006915
Filing Date
2018-11-06
Accepted
2018-11-06 16:02:19
Documents
52
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 m103018110q.htm 10-Q 345966
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 35721
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 70035
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 8568
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 8086
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 4216
7 EXHIBIT 32.2 ex32_2.htm EX-32.2 4628
  Complete submission text file 0001214659-18-006915.txt   2532511

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE hgen-20180930.xml EX-101.INS 346088
9 XBRL SCHEMA FILE hgen-20180930.xsd EX-101.SCH 36869
10 XBRL CALCULATION FILE hgen-20180930_cal.xml EX-101.CAL 37883
11 XBRL DEFINITION FILE hgen-20180930_def.xml EX-101.DEF 127313
12 XBRL LABEL FILE hgen-20180930_lab.xml EX-101.LAB 273375
13 XBRL PRESENTATION FILE hgen-20180930_pre.xml EX-101.PRE 195056
Mailing Address 533 AIRPORT BLVD. SUITE 200 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 200 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 181162926
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1